The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue.
COVID-19
Coronavirus
France
Hesitancy
Ideology
Partisanship
Politics
Vaccination
Journal
Social science & medicine (1982)
ISSN: 1873-5347
Titre abrégé: Soc Sci Med
Pays: England
ID NLM: 8303205
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
revised:
22
09
2020
accepted:
30
09
2020
pubmed:
11
10
2020
medline:
9
1
2021
entrez:
10
10
2020
Statut:
ppublish
Résumé
As Covid-19 spreads across the world, governments turn a hopeful eye towards research and development of a vaccine against this new disease. But it is one thing to make a vaccine available, and it is quite another to convince the public to take the shot, as the precedent of the 2009 H1N1 influenza illustrated. In this paper, we present the results of four online surveys conducted in April 2020 in representative samples of the French population 18 years of age and over (N = 5018). These surveys were conducted during a period when the French population was on lockdown and the daily number of deaths attributed to the virus reached its peak. We found that if a vaccine against the new coronavirus became available, almost a quarter of respondents would not use it. We also found that attitudes to this vaccine were correlated significantly with political partisanship and engagement with the political system. Attitudes towards this future vaccine did not follow the traditional mapping of political attitudes along a Left-Right axis. The rift seems to be between people who feel close to governing parties (Centre, Left and Right) on the one hand, and, on the other, people who feel close to Far-Left and Far-Right parties as well as people who do not feel close to any party. We draw on the French sociological literature on ordinary attitudes to politics to discuss our results as well as the cultural pathways via which political beliefs can affect perceptions of vaccines during the COVID-19 pandemic.
Identifiants
pubmed: 33038683
pii: S0277-9536(20)30633-X
doi: 10.1016/j.socscimed.2020.113414
pmc: PMC7537647
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
113414Investigateurs
Patrick Peretti-Watel
(P)
Valérie Seror
(V)
Sébastien Cortaredona
(S)
Odile Launay
(O)
Jocelyn Raude
(J)
Pierre Verger
(P)
François Beck
(F)
Stéphane Legleye
(S)
Olivier L'Haridon
(O)
Jeremy Ward
(J)
Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Références
Vaccine. 2019 May 21;37(23):2993-2997
pubmed: 31031028
Nat Immunol. 2019 Oct;20(10):1257-1259
pubmed: 31477920
PLoS One. 2018 Jan 25;13(1):e0191728
pubmed: 29370265
Eur J Public Health. 2010 Oct;20(5):490-4
pubmed: 20444821
Soc Sci Med. 2016 Jun;159:48-57
pubmed: 27173740
PLoS One. 2016 Jul 08;11(7):e0158382
pubmed: 27391965
Lancet. 2020 May 2;395(10234):1405-1406
pubmed: 32243778
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
Patient Educ Couns. 2019 Jan;102(1):172-179
pubmed: 30166057
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Lancet Infect Dis. 2020 Jul;20(7):769-770
pubmed: 32445713
SSM Popul Health. 2018 Dec 14;7:100342
pubmed: 30793020
Nature. 2020 May;581(7808):251
pubmed: 32405043